The 0.6mg/kg +4 days of 0.3mg/kg that is being used in the covid19 trial had the Highest early clinical response in the ABSSSI trial.
Ph2b ABSSSI Study: Early Clinical Response at 48-72 hours.
0.6mg/kg 92.2% 1 dose
0.8mg/kg 95% 1 dose
0.6mg/kg(+2 days of 0.3mg/kg) 98.1%
Ph2b ABSSSI Study: Early Clinical Response at 48-72 hours.
0.6mg/kg 92.2% 1 dose
0.8mg/kg 95% 1 dose
0.6mg/kg(+2 days of 0.3mg/kg) 98.1%
7
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Leo Took The Money and Ran